期刊文献+

银屑病患者抑郁和焦虑的调查及其对共患病的影响 被引量:10

Investigation of depression and anxiety in the patients with psoriasis and the influence on comorbidity
下载PDF
导出
摘要 目的:研究银屑病患者抑郁和焦虑的状况及其对共患病的影响。方法:采用一般情况问卷(自行设计)及抑郁自评量表(SDS)、焦虑自评量表(SAS)对来我院就诊的184例银屑病患者进行调查及评定。结果:184例患者中,合并抑郁或焦虑的银屑病患者113例(61.41%)。合并抑郁或焦虑的银屑病患者与不合并抑郁或焦虑相比发生心血管疾病、脑血管疾病、糖尿病、高血压和高脂血症的比例更高。结论:抑郁或焦虑是银屑病患者发生心血管疾病、脑血管疾病、糖尿病、高血压、高脂血症的独立危险因素。 Objective:To investigate the status of depression and anxiety in the patients with psoriasis and the influence on comorbidity.Methods:One hundred and eighty-four patients with psoriasis in our hospital were investigated and evaluated by general condition questionnaire(self-designed),depression self-rating scale(SDS)and anxiety self-rating scale(SAS).Results:Of 184 patients,113(61.41%)patients sufferred from depression or anxiety.The occurrence rates of comorbidity of cardiovascular disease,cerebrovascular disease,diabetes,hypertension and hyperlipidemia in the patients with depression or anxiety was higher than the patients without depression or anxiety.Conclusion:Depression or anxiety is a risk factor for cardiovascular disease,cerebrovascular disease,diabetes,hypertension and hyperlipidemia in the patients with psoriasis.
作者 王倩 江水 陈官芝 苏磊 王宗岭 陈宏泉 郁博 乔霞 WANG Qian;JIANG Shui;CHEN Guanzhi;SU Lei;WANG Zongling;CHEN Hongquan;YU Bo;QIAO Xia(Affiliated Hospital of Qingdao University,Qingdao 266003,China)
出处 《中国麻风皮肤病杂志》 2020年第10期584-587,604,共5页 China Journal of Leprosy and Skin Diseases
基金 山东省医药卫生科技发展计划项目(编号:2017WS636)。
关键词 银屑病 抑郁 焦虑 共患病 psoriasis depression anxiety comorbidity
  • 相关文献

参考文献4

二级参考文献43

  • 1Onumah N, Kircik LH. Psoriasis and its comorbidities [ J ]. J Drugs Dermatol, 2012, 11 (5 Suppl) : $5-10.
  • 2Mrowietz U, Steinz K, Gerdes S. Psoriasis: to treat or to manage? [J]. Exp Dermatol, 2014, 23( 10): 705-709.
  • 3Mehta NN, Yu Y, Pinnelas R, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events [J]. Am J Med, 2011, 124(8): 775.
  • 4Prodanovich S, Kirsner RS, Kravetz JD, et al. Assoeiation of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases andmortality [J]. Arch Dermatol, 2009, 145(6): 700-703.
  • 5Daudrn E, Castafieda S, SuOrez C, et al. Clinieal practice guideline for an integrated approach to comorbidity in patients with psoriasis [J].J Eur Acad Dermatol Venereol, 2013, 27( 11 ): 1387-1404.
  • 6Montaudi6 H, Albert-Sabonnadi~re C, Acquaealda E, et al. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of eomorbidities andcardiovaseular risk: results of a prospective longitudinal observational study [J]. J Eur Aead Dermatol Venereol, 2014, 28 (9): 1186-1191.
  • 7Mieha R, Imamura F, Wyler von Balhnoos M, et al. Systematic review and meta-analysis of methotrexate use and risk of eardiovaseular disease [J].Am J Cardiol, 2011, 108 (9): 1362- 1370.
  • 8Famenini S, Sako EY, Wu JJ. Effect of treating psoriasis on cardiovascular eomorbidities: focus on TNF inhibitors[J]. Am J Clin Dermatol, 2014, 15( 1 ): 45-50.
  • 9Ameriean Academy of Dermatology Work Group, Menter A, Korman NJ, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions [J]. J Am Acad Dennatol, 2011, 65( 1 ): 137-174.
  • 10Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease [J]. Clin Dermatol, 2014, 32(3 ): 343-350.

共引文献40

同被引文献120

引证文献10

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部